BR0012613A - Alo-anticorpos anti-fator viii catalìticos - Google Patents
Alo-anticorpos anti-fator viii catalìticosInfo
- Publication number
- BR0012613A BR0012613A BR0012613-6A BR0012613A BR0012613A BR 0012613 A BR0012613 A BR 0012613A BR 0012613 A BR0012613 A BR 0012613A BR 0012613 A BR0012613 A BR 0012613A
- Authority
- BR
- Brazil
- Prior art keywords
- factor viii
- allo
- antibodies
- catalytic
- factor
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Patente de Invenção para "ALO-ANTICORPOS ANTI-FATOR VIII CATALìTICOS". A presente invenção se refere a um processo para determinar a presença de alo-anticorpos anti-Fator VIII catalíticos, capazes de degradar Fator VIII em um mamífero e de caracterização de sítios de clivagem na molécula de Fator VIII, pelos alo-anticorpos anti-Fator VIII catalíticos. Ela também se refere a um inibidor de degradação de alo-aticorpo anti-Fator VIII-Fator VIII catalisado; a uma composição farmacêutica compreendendo os alo-anticorpos anti-Fator VIII catalíticos que são capazes de degradar o Fator VIII e que se originam do processo de determinação; e adicionalmente à composição farmacêutica compreendendo o inibidor de degradição de alo-anticorpo anti-fator VIII-Fator VIII catalisado. Finalmente, a presente invenção se refere a aplicação em terapêuticos, do inibidor de degradação de alo-anticorpo anti-Fator VIII-Fator VIII catalisado de uma composição farmacêutica compreendendo os alo-anticorpos anti-Fator VIII catalíticos que são capazes de degradar o Fator VIII e que se originam do processo de determinação e de uma composição farmacêutica compreendendo o inibidor de degradação de alo-anticorpo anti-Fator VIII-Fator VIII catalisado.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99401841A EP1074842A1 (en) | 1999-07-21 | 1999-07-21 | Catalytic anti-factor VIII allo-antibodies |
| PCT/EP2000/006870 WO2001007918A1 (en) | 1999-07-21 | 2000-07-18 | Catalytic anti-factor viii allo-antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0012613A true BR0012613A (pt) | 2002-04-09 |
Family
ID=8242069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0012613-6A BR0012613A (pt) | 1999-07-21 | 2000-07-18 | Alo-anticorpos anti-fator viii catalìticos |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7507540B1 (pt) |
| EP (2) | EP1074842A1 (pt) |
| JP (2) | JP2003505434A (pt) |
| KR (1) | KR100788435B1 (pt) |
| CN (1) | CN1229646C (pt) |
| AU (1) | AU777615B2 (pt) |
| BR (1) | BR0012613A (pt) |
| CA (1) | CA2379818A1 (pt) |
| CZ (1) | CZ2002248A3 (pt) |
| EE (1) | EE200200034A (pt) |
| HK (1) | HK1044372A1 (pt) |
| HU (1) | HUP0201941A3 (pt) |
| IL (1) | IL147700A0 (pt) |
| IS (1) | IS6238A (pt) |
| MX (1) | MXPA02000752A (pt) |
| NO (1) | NO20020253L (pt) |
| NZ (1) | NZ516702A (pt) |
| PL (1) | PL353739A1 (pt) |
| RU (1) | RU2258935C2 (pt) |
| SK (1) | SK862002A3 (pt) |
| TR (1) | TR200200340T2 (pt) |
| UA (1) | UA75867C2 (pt) |
| WO (1) | WO2001007918A1 (pt) |
| ZA (1) | ZA200200351B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY166429A (en) | 2010-11-17 | 2018-06-26 | Chugai Pharmaceutical Co Ltd | Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii |
| FR2969761A1 (fr) * | 2010-12-22 | 2012-06-29 | Lfb Biotechnologies | Procede de dosage d'anticorps diriges contre le facteur viii |
| TWI700300B (zh) | 2014-09-26 | 2020-08-01 | 日商中外製藥股份有限公司 | 中和具有第ｖｉｉｉ凝血因子（ｆｖｉｉｉ）機能替代活性的物質之抗體 |
| TWI701435B (zh) | 2014-09-26 | 2020-08-11 | 日商中外製藥股份有限公司 | 測定ｆｖｉｉｉ的反應性之方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744446A (en) * | 1992-04-07 | 1998-04-28 | Emory University | Hybrid human/animal factor VIII |
| WO1994011013A1 (en) * | 1992-11-13 | 1994-05-26 | Duke University | Chimeric blood coagulation proteins |
| US5910481A (en) * | 1995-11-13 | 1999-06-08 | Immuno Ag | Hybrid proteins with modified activity |
| US5744326A (en) * | 1996-03-11 | 1998-04-28 | The Immune Response Corporation | Use of viral CIS-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sites |
-
1999
- 1999-07-21 EP EP99401841A patent/EP1074842A1/en not_active Withdrawn
-
2000
- 2000-07-18 CA CA002379818A patent/CA2379818A1/en not_active Abandoned
- 2000-07-18 TR TR2002/00340T patent/TR200200340T2/xx unknown
- 2000-07-18 HU HU0201941A patent/HUP0201941A3/hu unknown
- 2000-07-18 AU AU68245/00A patent/AU777615B2/en not_active Ceased
- 2000-07-18 PL PL00353739A patent/PL353739A1/xx not_active Application Discontinuation
- 2000-07-18 MX MXPA02000752A patent/MXPA02000752A/es unknown
- 2000-07-18 BR BR0012613-6A patent/BR0012613A/pt not_active Application Discontinuation
- 2000-07-18 CZ CZ2002248A patent/CZ2002248A3/cs unknown
- 2000-07-18 UA UA2002010487A patent/UA75867C2/uk unknown
- 2000-07-18 EP EP00956204A patent/EP1196782A1/en not_active Withdrawn
- 2000-07-18 US US10/031,938 patent/US7507540B1/en not_active Expired - Fee Related
- 2000-07-18 SK SK86-2002A patent/SK862002A3/sk unknown
- 2000-07-18 NZ NZ516702A patent/NZ516702A/en unknown
- 2000-07-18 WO PCT/EP2000/006870 patent/WO2001007918A1/en active IP Right Grant
- 2000-07-18 RU RU2002101123/15A patent/RU2258935C2/ru not_active IP Right Cessation
- 2000-07-18 EE EEP200200034A patent/EE200200034A/xx unknown
- 2000-07-18 KR KR1020027000657A patent/KR100788435B1/ko not_active IP Right Cessation
- 2000-07-18 CN CNB008106339A patent/CN1229646C/zh not_active Expired - Fee Related
- 2000-07-18 IL IL14770000A patent/IL147700A0/xx not_active IP Right Cessation
- 2000-07-18 JP JP2001512295A patent/JP2003505434A/ja active Pending
-
2002
- 2002-01-15 ZA ZA200200351A patent/ZA200200351B/en unknown
- 2002-01-16 IS IS6238A patent/IS6238A/is unknown
- 2002-01-17 NO NO20020253A patent/NO20020253L/no not_active Application Discontinuation
- 2002-07-24 HK HK02105463.5A patent/HK1044372A1/zh unknown
-
2009
- 2009-01-16 US US12/320,077 patent/US20090208512A1/en not_active Abandoned
- 2009-07-27 JP JP2009174550A patent/JP2009292823A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| KR100788435B1 (ko) | 2007-12-24 |
| EP1074842A1 (en) | 2001-02-07 |
| RU2258935C2 (ru) | 2005-08-20 |
| EP1196782A1 (en) | 2002-04-17 |
| US20090208512A1 (en) | 2009-08-20 |
| CN1361865A (zh) | 2002-07-31 |
| KR20020042618A (ko) | 2002-06-05 |
| HUP0201941A2 (en) | 2002-10-28 |
| UA75867C2 (en) | 2006-06-15 |
| CN1229646C (zh) | 2005-11-30 |
| MXPA02000752A (es) | 2003-07-14 |
| JP2003505434A (ja) | 2003-02-12 |
| TR200200340T2 (tr) | 2003-01-21 |
| AU6824500A (en) | 2001-02-13 |
| SK862002A3 (en) | 2002-06-04 |
| WO2001007918A1 (en) | 2001-02-01 |
| NZ516702A (en) | 2003-10-31 |
| JP2009292823A (ja) | 2009-12-17 |
| PL353739A1 (en) | 2003-12-01 |
| US7507540B1 (en) | 2009-03-24 |
| IL147700A0 (en) | 2002-08-14 |
| HUP0201941A3 (en) | 2005-01-28 |
| NO20020253L (no) | 2002-03-13 |
| CA2379818A1 (en) | 2001-02-01 |
| NO20020253D0 (no) | 2002-01-17 |
| CZ2002248A3 (cs) | 2002-07-17 |
| IS6238A (is) | 2002-01-16 |
| AU777615B2 (en) | 2004-10-21 |
| HK1044372A1 (zh) | 2002-10-18 |
| EE200200034A (et) | 2003-06-16 |
| ZA200200351B (en) | 2003-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0009564A (pt) | Utilização de inibidores da cyp2d6 em terapias de combinação | |
| BR0009167A (pt) | Inibidores de enzima impdh | |
| BR0010555A (pt) | Inibidores de neuraminidases | |
| BRPI0609121B8 (pt) | 1h-benzimidazol-4-carboxamidas substituídas com um carbono quaternário na posição 2 | |
| BR0309576A (pt) | Variante de polipeptìdeo do fator vii (fvii) ou fator viia (fviia), sequência de nucleotìdeo, vetor de expressão, célula hospedeira, composição farmacêutica, uso de uma variante, e, método para tratar um mamìfero que tenha uma doença ou um distúrbio em que a formação de coágulo é desejável | |
| BRPI0109131B8 (pt) | dna, vetor de expressão compreendendo o mesmo, fator viii modificado de porcino, seu processo de produção e composição terapêutica compreendendo o mesmo | |
| NO20076634L (no) | Erythropoietin reseptorpeptidformuleringer og anvendelser | |
| BRPI0520669A2 (pt) | dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina | |
| BRPI0409624A (pt) | 2-hidróxi-3-diaminoalcanos de benzamida | |
| BRPI0512084A (pt) | heterociclos de cinco membros úteis como inibidores de serina protease, composição farmacêutica contendo os mesmos, bem como seu uso | |
| BR0113669A (pt) | Inibidores da desacetilase | |
| BR0112104A (pt) | Processos para tratamento de doenças reumáticas usando uma molécula de ctla4 solúvel | |
| BR0008922A (pt) | Compostos úteis como agentes antiinflamatórios | |
| UY27558A1 (es) | Inhibidores del factor xa y de otras proteasas de serina implicadas en la cascada de la coagulación | |
| EA200900828A1 (ru) | Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1 | |
| BR0008440A (pt) | Inibidor de metaloprotease de sulfamato do ácido hidroxâmico | |
| IS6997A (is) | Lyfjafræðilega virkir úridín esterar | |
| BRPI0409627A (pt) | 2-hidróxi-3-diaminoalcanos de fenacila | |
| BRPI0412298A (pt) | inibidores de cascata de complemento conjugado | |
| PA8467401A1 (es) | Procedimiento para tratar la insuficiencia cardiaca | |
| BRPI0506493A (pt) | combinações terapêuticas | |
| BR9815596A (pt) | Composto, composição farmacêutica, método de tratamento de doenças inflamatórias e método de tratamento de condição ou doença mediada por mmps e/ou tnf e/ou agrecanase | |
| BR0112337A (pt) | Derivados de fosfolipìdeos de ácido valpróico e suas misturas | |
| BR0012613A (pt) | Alo-anticorpos anti-fator viii catalìticos | |
| BR0209128A (pt) | Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |